AI in Pharmacovigilance: Why Governance Will Define Success
As adoption accelerates, organizations must ensure that the use of AI strengthens and not weakens accountability and patient safety.
The Future of Pharmacovigilance Technology: How AI and Automation Are Redefining Drug Safety
For many organizations, the workload has become too large for manual review alone. AI and automation are stepping in, not to replace the human element, but to restore focus to it.
presented by
From Blind Spots to Better Outcomes: How SNF Data Transparency Strengthens LTSS
What if health plans could identify member decline before an avoidable hospitalization occurs? Real-time clinical visibility into long-stay SNF members uncovers risk earlier and drives better outcomes.
StartUPDATES: New Developments from Healthcare Startups
Check out news from Oral Genome, Planyear, Graph AI, Vega Health and more.
GenAI and Pharmacovigilance: Perfect is the Enemy of Good
Disregarding novel developments on account of imperfection will postpone the advancement of scientific discovery.
Belgium’s UCB to incorporate Accenture’s AI tech into pharmacovigilance efforts
The Belgian drugmaker will use Accenture's INTIENT Pharmacovigilance to monitor the safety of its drugs, including those that are on the market and in clinical trials. Germany's Bayer inked a similar deal with Genpact last year.